THE U.S. PREVENTATIVE SERVICES TASK FORCE published a B recommendation for low-dose aspirin use for the primary prevention of colorectal cancer and cardiovascular disease in adults aged 50 to 59 years who have a 10 percent or greater 10-year CVD risk, are not at increased risk for bleeding, have a life expectancy of at least...
Last week, Richard Pazdur was named to the position of director of FDA’s Center for Drug Evaluation and Research. Much has been written about how Pazdur, with nearly a three-decade long career at the agency, represents a stabilizing choice for FDA as it faces inner and outer turmoil.
